Risk Minimisation Materials

Abacavir Hypersensitivity Educational Slides for Healthcare Professionals

Abacavir Hypersensitivity Educational Slides for Healthcare Professionals

For Healthcare Professionals

Abacavir Patient Alert Card

Abacavir Patient Alert Card

Abacavir - Alert Card

Important - Alert Card for Medicines Containing Abacavir

Abacavir Brochure Risk Minimisation

Key Risk Minimisation Points - Abacavir Hypersensitivity Reaction

For Healthcare Professionals

Abacavir / Lamivudine Patient Alert Card

Patient Alert Card for Medicines Containing Abacavir

Hypersensitivity Reactions to Abacavir / Lamivudine educational material

Abacavir hypersensitivity reaction key risk minimisation points

For Healthcare Professionals

Abacavir Alert Card

Important - Alert Card for Medicines Containing Abacavir.

Abacavir Brochure Risk Minimisation

Key Risk Minimisation Points - Abacavir Hypersensitivity Reaction

For Healthcare Professionals

Abacavir Alert Card

Alert Card for Medicines Containing Abacavir

Abacavir Brochure Risk Minimisation

Information on Abacavir Hypersensitivity Reaction

For Healthcare Professionals

Abacavir HSR brochure

Abacavir Hypersensitivity Reaction (HSR) Key Risk Minimisation Points

Abacavir Patient Alert Card

Since your medicine contains Abacavir some patients taking it may develop a hypersensitivity reaction (serious allergic reaction) which can be life-threatening if treatment is continued.

Abacavir Hypersensitivity Reaction; Brochure

Abacavir hypersensitivity reaction Key risk minimisation points: Abacavir Hypersensitivity Reaction (HSR)

Abacavir Lamivude Alert Card

Important - Alert Card Medicines containing Abacavir Carry this card with you at all times

Abstral Patient and Carer Guide

Abstral (fentanyl citrate) sublingual tablets - Important risk minimisation information for patients and their carers

Abstral Patient and Carer Guide

Abstral (fentanyl citrate) sublingual tablets - Important risk minimisation information for patients and their carers

Abstral Prescriber Guide

Abstral (fentanyl citrate) sublingual tablets - Important risk minimisation information for healthcare professionals

For Healthcare Professionals

Abstral Prescriber Guide

Abstral (fentanyl citrate) sublingual tablets - Important risk minimisation information for healthcare professionals

For Healthcare Professionals

Patient Guide for Actiq® (fentanyl citrate) Lozenges

Patient Guide For Actiq® (fentanyl citrate) Lozenges

Patient Treatment Diary for Actiq® (fentanyl citrate) Lozenge

This Treatment Diary is designed to help you monitor your experience of BTcP and your use of Actiq®. It will give you and your doctor a valuable insight into your progress and ensure you are receiving the correct level of treatment

Prescription Guide for Healthcare Professionals for Actiq (fentanyl citrate) Lozenge

This guide is designed to provide information around the use of Actiq® (fentanyl citrate) lozenges for Healthcare Professionals (HCPs). More specifically, identifying appropriate patients and correctly prescribing Actiq® to minimise the risk of misuse/pharmacodependence, abuse, medication errors, drug diversion, accidental exposure, overdose, off-label use, respiratory depression and local tolerability (dental decay) in patients not receiving opioid background therapy.

For Healthcare Professionals

Adasuve HCP Guide - HCP use

Adasuve HCP Guide - HCP use

For Healthcare Professionals

Alzest instructions for use and patient diary June 2018

Amfexa - Educational Risk Minimisation Materials to help reduce the risk with using this medicine.

HEALTHCARE PROFESSIONALS GUIDE TO PRESCRIBING WEBSITE Website to host materials for healthcare professionals to support appropriate prescribing of dexamfetamine sulphate

For Healthcare Professionals

AMGEVITA Patient alert card - adult

This card has important safety information about AMGEVITA. To request a copy of the patient alert card please contact Amgen medical information on 01223 436441 or by email to GBINFOLINE@AMGEN.COM.

AMGEVITA Patient alert card - paediatric

This card has important safety information about AMGEVITA. To request a copy of the patient alert card please contact Amgen medical information on 01223 436441 or by email to GBINFOLINE@AMGEN.COM.

AMGEVITA Safety Monograph

This monograph contains important safety information about AMGEVITA and advice on risk minimisation. If you require additional information or copies of the AMGEVITA risk minimisation materials, please contact Amgen medical information on 01223 436441 or email gbinfoline@amgen.com

For Healthcare Professionals

Arava- Prescriber Guide- HCP and Patients

For hard copies please contact our medical information department at 0845 372 7101 or email uk-medicalinformation@sanofi.com .

ARAVA- Risk Minimisation Educational Material for HCP

Risk Minimisation Educational Material for HCP Specific Safety Information For hard copies please contact our medical information department at 0845 372 7101 or email uk-medicalinformation@sanofi.com .

For Healthcare Professionals

Aripiprazole (Patient-Caregiver) Brochure

This booklet will help you and your caregiver(s) understand what Aripiprazole is and why it was chosen for you, as well as what to expect during treatment. This booklet also includes information about potential side effects associated with Aripiprazole treatment and the importance of immediately reporting any symptoms of these side effects to your doctor. Hard copies of the FAQ & Patient-Caregiver brochure are available on request from our Medical Information Department at 01271 385257 or e-mail: Medinfo@accord-healthcare.com

Aripiprazole FAQ Brochure

These frequently asked questions are provided by Actavis for doctors, nurses and other healthcare professionals who use Aripiprazole to treat adolescent patients with bipolar I disorder. This document will enable you to: • Understand how Aripiprazole is used to treat adolescent patients with bipolar I disorder • Provide important information to adolescent patients with bipolar I disorder and their caregiver(s) • Understand potential adverse reactions in adolescent patients with bipolar I disorder who are treated with Aripiprazole • Present the Patient/Caregiver Information Brochure and its objectives to adolescent patients with bipolar I disorder

For Healthcare Professionals

Aripiprazole Accord Educational leaflet for Patients and Caregivers

Patient and Caregiver risk minimisation educational leaflet for Aripiprazole Accord 5mg, 10mg, 15mg and 30mg Tablets. For further information please contact our medical information department Medical Information e-mail: uk@accord-healthcare.com Medical Information Fax: +44 (0)208 861 4867 Medical Information Direct Line: +44 (0)208 901 3370

Aripiprazole Accord HCP Q&A Brochure

Healthcare Professional Q&A Brochure for Aripiprazole Accord 5mg, 10mg, 15mg and 30mg Tablets. For further information please contact our medical information department Medical Information e-mail: uk@accord-healthcare.com Medical Information Fax: +44 (0)208 861 4867 Medical Information Direct Line: +44 (0)208 901 3370

For Healthcare Professionals

Aubagio (teriflunomide) – Healthcare professional (HCP) – Education / Discussion Guide - Risk Minimisation Information for Healthcare Professionals

At first prescription, the prescriber/healthcare professional (HCP) should discuss with the patient the risks described within the discussion guide.

For Healthcare Professionals

Aubagio (teriflunomide) – Patient Card - Risk Minimisation Information for Patients

The Patient Card contains important safety information the patient needs to be aware of when receiving treatment with Aubagio (teriflunomide). At first prescription, the prescriber/healthcare professional (HCP) should provide the Patient Card.